Immunotherapy Market Report

China Immunotherapy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 15, 2023
  • PAGES：196
  • REPORT CODE：GMM1798917
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases. Some types of immunotherapy only target certain cells of the immune system. Others affect the immune system in a general way.

    This report elaborates on the current development of the Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer Inc

    • Bristol-Myers Squibb

    • Novartis International AG

    • GlaxoSmithKline Plc

    • AbbVie Inc

    • NBE Therapeutics

    • Johnson & Johnson

    • Bluebird Bio

    • BioNTech SE

    • Gilead Sciences, Inc

    • F Hoffmann-La Roche Ltd

    • OSE Immunotherapeutic

    • Amgen Inc

    • Teva Pharmaceuticals

    • AstraZeneca

    • Sanofi

    • Vitaeris

    • Merck & Co Inc

    • Juno Therapeutics

    By Type:

    • Other Immunotherapies

    • Interferon & Interleukin

    • Checkpoint Inhibitors

    • Monoclonal Antibodies

    By Application:

    • Cancer

    • Infectious Diseases

    • Autoimmune Diseases

    • Inflammatory Bowel Diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Immunotherapy Market Overview 2018-2029

    • 1.1 China Immunotherapy Industry Development Overview

    • 1.2 China Immunotherapy Industry Development History

    • 1.3 China Immunotherapy Industry Market Size (2018-2029)

    • 1.4 China Immunotherapy Market Analysis by Type from Production Side

      • 1.4.1 China Immunotherapy Production Volume, Production Value and Growth Rate of Other Immunotherapies (2018-2029)

      • 1.4.2 China Immunotherapy Production Volume, Production Value and Growth Rate of Interferon & Interleukin (2018-2029)

      • 1.4.3 China Immunotherapy Production Volume, Production Value and Growth Rate of Checkpoint Inhibitors (2018-2029)

      • 1.4.4 China Immunotherapy Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • 1.5 China Immunotherapy Market Analysis by Application from Consumption End

      • 1.5.1 China Immunotherapy Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.2 China Immunotherapy Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.3 China Immunotherapy Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

      • 1.5.4 China Immunotherapy Sales Volume, Sales Value and Growth Rate of Inflammatory Bowel Diseases (2018-2029)

    • 1.6 China Immunotherapy Market Analysis by Region

      • 1.6.1 North China Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Immunotherapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Immunotherapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Immunotherapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Immunotherapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Immunotherapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Immunotherapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Immunotherapy Industry Development

    Chapter 3 ImmunotherapyIndustry Chain Analysis

    • 3.1 Immunotherapy Industry Chain

    • 3.2 Immunotherapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Immunotherapy Market

    • 3.3 Immunotherapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Immunotherapy Market

    Chapter 4 China Immunotherapy Market, by Type

    • 4.1 China Immunotherapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Immunotherapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Immunotherapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Immunotherapy Production Volume and Growth Rate of Other Immunotherapies

      • 4.5.2 China Immunotherapy Production Volume and Growth Rate of Interferon & Interleukin

      • 4.5.3 China Immunotherapy Production Volume and Growth Rate of Checkpoint Inhibitors

      • 4.5.4 China Immunotherapy Production Volume and Growth Rate of Monoclonal Antibodies

    Chapter 5 China Immunotherapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Immunotherapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Immunotherapy Market Size and Growth Rate, by Application

      • 5.5.1 China Immunotherapy Market Size and Growth Rate of Cancer

      • 5.5.2 China Immunotherapy Market Size and Growth Rate of Infectious Diseases

      • 5.5.3 China Immunotherapy Market Size and Growth Rate of Autoimmune Diseases

      • 5.5.4 China Immunotherapy Market Size and Growth Rate of Inflammatory Bowel Diseases

    Chapter 6 China Immunotherapy Market, by Region

    • 6.1 China Immunotherapy Production Volume and Production Value, by Region

    • 6.2 China Immunotherapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Immunotherapy Market Analysis

    • 7.1 North China Immunotherapy Market, by Type

    • 7.2 North China Immunotherapy Market, by Application

    Chapter 8 Central China Immunotherapy Market Analysis

    • 8.1 Central China Immunotherapy Market, by Type

    • 8.2 Central China Immunotherapy Market, by Application

    Chapter 9 South China Immunotherapy Market Analysis

    • 9.1 South China Immunotherapy Market, by Type

    • 9.2 South China Immunotherapy Market, by Application

    Chapter 10 East China Immunotherapy Market Analysis

    • 10.1 East China Immunotherapy Market, by Type

    • 10.2 East China Immunotherapy Market, by Application

    Chapter 11 Northeast China Immunotherapy Market Analysis

    • 11.1 Northeast China Immunotherapy Market, by Type

    • 11.2 Northeast China Immunotherapy Market, by Application

    Chapter 12 Southwest China Immunotherapy Market Analysis

    • 12.1 Southwest China Immunotherapy Market, by Type

    • 12.2 Southwest China Immunotherapy Market, by Application

    Chapter 13 Northwest China Immunotherapy Market Analysis

    • 13.1 Northwest China Immunotherapy Market, by Type

    • 13.2 Northwest China Immunotherapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer Inc

        • 14.1.1 Pfizer Inc Company Profile

        • 14.1.2 Pfizer Inc Immunotherapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol-Myers Squibb

        • 14.2.1 Bristol-Myers Squibb Company Profile

        • 14.2.2 Bristol-Myers Squibb Immunotherapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novartis International AG

        • 14.3.1 Novartis International AG Company Profile

        • 14.3.2 Novartis International AG Immunotherapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline Plc

        • 14.4.1 GlaxoSmithKline Plc Company Profile

        • 14.4.2 GlaxoSmithKline Plc Immunotherapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AbbVie Inc

        • 14.5.1 AbbVie Inc Company Profile

        • 14.5.2 AbbVie Inc Immunotherapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 NBE Therapeutics

        • 14.6.1 NBE Therapeutics Company Profile

        • 14.6.2 NBE Therapeutics Immunotherapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Johnson & Johnson

        • 14.7.1 Johnson & Johnson Company Profile

        • 14.7.2 Johnson & Johnson Immunotherapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bluebird Bio

        • 14.8.1 Bluebird Bio Company Profile

        • 14.8.2 Bluebird Bio Immunotherapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 BioNTech SE

        • 14.9.1 BioNTech SE Company Profile

        • 14.9.2 BioNTech SE Immunotherapy Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Gilead Sciences, Inc

        • 14.10.1 Gilead Sciences, Inc Company Profile

        • 14.10.2 Gilead Sciences, Inc Immunotherapy Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 F Hoffmann-La Roche Ltd

        • 14.11.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.11.2 F Hoffmann-La Roche Ltd Immunotherapy Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 OSE Immunotherapeutic

        • 14.12.1 OSE Immunotherapeutic Company Profile

        • 14.12.2 OSE Immunotherapeutic Immunotherapy Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Amgen Inc

        • 14.13.1 Amgen Inc Company Profile

        • 14.13.2 Amgen Inc Immunotherapy Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Teva Pharmaceuticals

        • 14.14.1 Teva Pharmaceuticals Company Profile

        • 14.14.2 Teva Pharmaceuticals Immunotherapy Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 AstraZeneca

        • 14.15.1 AstraZeneca Company Profile

        • 14.15.2 AstraZeneca Immunotherapy Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Sanofi

        • 14.16.1 Sanofi Company Profile

        • 14.16.2 Sanofi Immunotherapy Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Vitaeris

        • 14.17.1 Vitaeris Company Profile

        • 14.17.2 Vitaeris Immunotherapy Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Merck & Co Inc

        • 14.18.1 Merck & Co Inc Company Profile

        • 14.18.2 Merck & Co Inc Immunotherapy Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Juno Therapeutics

        • 14.19.1 Juno Therapeutics Company Profile

        • 14.19.2 Juno Therapeutics Immunotherapy Market Performance

        • 14.19.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Immunotherapy Industry Research Conclusions

    • 15.2 Immunotherapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Immunotherapy Industry Market Size (2018-2029)

    • Figure China Immunotherapy Production Volume, Production Value and Growth Rate of Other Immunotherapies (2018-2029)

    • Figure China Immunotherapy Production Volume, Production Value and Growth Rate of Interferon & Interleukin (2018-2029)

    • Figure China Immunotherapy Production Volume, Production Value and Growth Rate of Checkpoint Inhibitors (2018-2029)

    • Figure China Immunotherapy Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Immunotherapy Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China Immunotherapy Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Immunotherapy Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

    • Figure China Immunotherapy Sales Volume, Sales Value and Growth Rate of Inflammatory Bowel Diseases (2018-2029)

    • Figure North China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure South China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure East China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Immunotherapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Immunotherapy Market Share by Type in 2018

    • Figure China Immunotherapy Market Share by Type in 2023

    • Figure China Immunotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Immunotherapy Production Volume and Growth Rate of Other Immunotherapies (2018-2023)

    • Figure China Immunotherapy Production Volume and Growth Rate of Interferon & Interleukin (2018-2023)

    • Figure China Immunotherapy Production Volume and Growth Rate of Checkpoint Inhibitors (2018-2023)

    • Figure China Immunotherapy Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Immunotherapy Market Share by Application in 2018

    • Figure China Immunotherapy Market Share by Application in 2023

    • Figure China Immunotherapy Total Market Size and Growth Rate from Consumption End

    • Figure China Immunotherapy Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China Immunotherapy Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Immunotherapy Market Size and Growth Rate of Autoimmune Diseases (2018-2023)

    • Figure China Immunotherapy Market Size and Growth Rate of Inflammatory Bowel Diseases (2018-2023)

    • Table China Immunotherapy Production Volume by Region (2018-2023)

    • Table China Immunotherapy Production Volume Share by Region (2018-2023)

    • Figure China Immunotherapy Production Volume Share by Region (2018-2023)

    • Table China Immunotherapy Production Value by Region (2018-2023)

    • Table China Immunotherapy Production Value Share by Region (2018-2023)

    • Figure China Immunotherapy Production Value Share by Region (2018-2023)

    • Table China Immunotherapy Sales Volume by Region (2018-2023)

    • Table China Immunotherapy Sales Volume Share by Region (2018-2023)

    • Figure China Immunotherapy Sales Volume Share by Region (2018-2023)

    • Table China Immunotherapy Sales Value by Region (2018-2023)

    • Table China Immunotherapy Sales Value Share by Region (2018-2023)

    • Figure China Immunotherapy Sales Value Share by Region (2018-2023)

    • Table North China Immunotherapy Production Volume by Type (2018-2023)

    • Table North China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure North China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table North China Immunotherapy Sales Volume by Application (2018-2023)

    • Table North China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure North China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Central China Immunotherapy Production Volume by Type (2018-2023)

    • Table Central China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Central China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Central China Immunotherapy Sales Volume by Application (2018-2023)

    • Table Central China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table South China Immunotherapy Production Volume by Type (2018-2023)

    • Table South China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure South China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table South China Immunotherapy Sales Volume by Application (2018-2023)

    • Table South China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure South China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table East China Immunotherapy Production Volume by Type (2018-2023)

    • Table East China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure East China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table East China Immunotherapy Sales Volume by Application (2018-2023)

    • Table East China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure East China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Immunotherapy Production Volume by Type (2018-2023)

    • Table Northeast China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northeast China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Immunotherapy Production Volume by Type (2018-2023)

    • Table Southwest China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Immunotherapy Sales Volume by Application (2018-2023)

    • Table Southwest China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Immunotherapy Production Volume by Type (2018-2023)

    • Table Northwest China Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northwest China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc Company Profile

    • Table GlaxoSmithKline Plc Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table NBE Therapeutics Company Profile

    • Table NBE Therapeutics Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Bluebird Bio Company Profile

    • Table Bluebird Bio Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table BioNTech SE Company Profile

    • Table BioNTech SE Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences, Inc Company Profile

    • Table Gilead Sciences, Inc Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table OSE Immunotherapeutic Company Profile

    • Table OSE Immunotherapeutic Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceuticals Company Profile

    • Table Teva Pharmaceuticals Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Vitaeris Company Profile

    • Table Vitaeris Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Inc Company Profile

    • Table Merck & Co Inc Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Juno Therapeutics Company Profile

    • Table Juno Therapeutics Immunotherapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US